CDC is requesting OMB approval for
3-years to implement a revised data collection form called, Report
of Verified Case of Tuberculosis (RVCT)for the national
tuberculosis (TB) surveillance system. Respondents to the revised
collection remain as before, territorial, state, and local public
health departments in 60 reporting areas (50 states, the District
of Columbia, New York City, Puerto Rico, and 7 jurisdictions in the
Pacific and Caribbean). This request updates the RVCT information
collection data collection form to reflect stakeholder requirements
and changes in TB diagnostics, drugs, and epidemiology since 1993.
In 1993, the RVCT was approved to collect information to monitor
factors essential to the reversal of the epidemic, including drug
resistance, risk factors such as HIV co-infection or living in
congregate settings such as prisons, and TB drug therapy. National
TB surveillance system data assist federal, state, and local public
health officials and policy makers in program planning, evaluation,
and resource allocation. CDC publishes summarized data on TB in the
United States annually, which is disseminated to TB control
officers, pulmonary and infectious disease experts, and others
interested in TB control.
US Code:
42
USC 301 Name of Law: Public Service Act
The changes incorporated into
the updated RVCT form are in response to requests by stakeholders
as described in section A.8 In brief, revisions to the currently
approved RVCT include ability to capture TB risk factors such as
diabetes, end-stage renal disease, anti-tumor necrosis factor alpha
therapy, and contact with an infectious TB case. Revisions to the
data collections will improve TB monitoring in the U.S. and
particularly for pediatric TB patients. The revisions to the data
collection will now reveal the primary reason for TB disease
evaluation, whether the patient moved during TB treatment,
immigration status for TB screening purposes, reason TB therapy
extended if more than one year, and susceptibility testing for
newer TB drugs. Enhancements to the RVCT will also accommodate
changes in diagnostic technology since 1993, such as nucleic acid
amplification tests, in
$1,146,526
No
Yes
Uncollected
Uncollected
Uncollected
Uncollected
Petunia Gissendaner
4046390164
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
Form CDC 72.9A Report of Verified Case of Tuberculosis (RVCT)
Attachment 7.pdf
Attachment 6.doc
Report of Verified Case of Tuberculosis (RVCT)